The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Expression of Concern: Glycogen synthase kinase 3β (GSK3β) mediates 6‐ hydroxydopamine‐induced neuronal death
Abstract
The causes of sporadic Parkinson's disease (PD) are poorly understood. 6‐Hydroxydopamine (6‐ OHDA), a PD mimetic, is widely used to model this neurodegenerative disorder in vitro and in vivo; however, the underlying mechanisms remain incompletely elucidated. We demonstrate here that 6‐ OHDA evoked endoplasmic reticulum (ER) stress, which was characterized by an up‐regulation in the expression of GRP78 and GADD153 (Chop), cleavage of procaspase‐12, and phosphorylation of eukaryotic initiation factor‐2 a in a human dopaminergic neuronal cell line (SH‐SY5Y) and cultured rat cerebellar granule neurons (CGNs). Glycogen synthase kinase‐3 β (GSK3β) responds to ER stress, and its activity is regulated by phosphorylation. 6‐OHDA significantly inhibited phosphorylation of GSK3β at Ser9, whereas it induced hyperphosphorylation of Tyr216 with little effect on GSK3β expression in SH‐SY5Y cells and PC12 cells (a rat dopamine cell line), as well as CGNs. Furthermore, 6‐OHDA decreased the expression of cyclin D1, a substrate of GSK3β, and dephosphorylated Akt, the upstream signaling component of GSK3β. Protein phosphatase 2A (PP2A), an ER stress‐responsive phosphatase, was involved in 6‐OHDA‐induced GSK3β dephosphorylation (Ser9). Blocking GSK3β activity by selective inhibitors (lithium, TDZD‐8, and L803‐mts) prevented 6‐OHDA‐induced cleavage of caspase‐3 and poly(ADP‐ribose) polymerase (PARP), DNA fragmentations and cell death. With a tetracycline (Tet)‐controlled TrkB inducible system, we demonstrated that activation of TrkB in SH‐ SY5Y cells alleviated 6‐OHDA‐induced GSK3β dephosphorylation (Ser9) and ameliorated 6‐OHDA neurotoxicity. TrkB activation also protected CGNs against 6‐OHDA‐induced damage. Although antioxidants also offered neuroprotection, they had little effect on 6‐OHDA‐induced GSK3β activation. These results suggest that GSK3β is a critical intermediate in pro‐apoptotic signaling cascades that are associated with neurodegenerative diseases, thus providing a potential target site amenable to pharmacological intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thastrup, O., Cullen, P. J., Drøbak, B. K., Hanley, M. R., & Dawson, A. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2466 · Cited by 3,270
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,256
Kaufman, R. J. (1999) · Genes & Development · doi:10.1101/gad.13.10.1211 · Cited by 2,248
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“Recent genetic evidence implies that ER stress is associated with Parkinson’s disease (PD) (6, 7).”
BackgroundMcCullough, K. D., Martindale, J. L., Klotz, L.-O., Aw, T.-Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,889
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Trk receptors: mediators of neurotrophin action
Patapoutian, A., & Reichardt, L. F. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00208-7 · Cited by 1,069
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Cellular Defenses against Unfolded Proteins
Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 991
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis
Morishima, N., Nakanishi, K., Takenouchi, H., Shibata, T., & Yasuhiko, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204973200 · Cited by 901
Lucas, J. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 900
Cohen, G., Heikkila, R. E., & MacNamee, W. T. T. A. O. D. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42751-8 · Cited by 897
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 1×
“Cyclin D1 is a substrate of GSK3β; phosphorylation of cyclin D1 by GSK3β facilitates an ubiquitindependent degradation of cyclin D1 (44, 45).”
BackgroundCoupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78
Rao, R. V., Peel, A., Logvinova, A., del Rio, G., Hermel, E., Yokota, T., Goldsmith, P. C., Ellerby, L. M., Ellerby, H. M., & Bredesen, D. E. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02289-5 · Cited by 573
Ryu, E. J., Harding, H. P., Angelastro, J. M., Vitolo, O. V., Ron, D., & Greene, L. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10690.2002 · Cited by 572
Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling
Mandic, A., Hansson, J., Linder, S., & Shoshan, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210284200 · Cited by 509
Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., LaFerla, F. M., Chan, S. L., Leissring, M. A., Shepel, P. N., & Geiger, J. D. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01548-4 · Cited by 505
Andjelković, M., Jakubowicz, T., Cron, P., Ming, X. F., Han, J. W., & Hemmings, B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5699 · Cited by 493
Cytotoxic and genotoxic potential of dopamine
Stokes, A. H., Hastings, T. G., & Vrana, K. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<659::aid-jnr1>3.0.co;2-c · Cited by 469
Martinez, A., Alonso, M., Castro, A., Pérez, C., & Moreno, F. J. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011020u · Cited by 455
Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal
Hetman, M., Cavanaugh, J. E., Kimelman, D., & Xia, Z. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02567.2000 · Cited by 440
Levites, Y., Amit, T., Youdim, M. B. H., & Mandel, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202832200 · Cited by 417
Welsh, G. I., & Proud, C. G. (1993) · Biochemical Journal · doi:10.1042/bj2940625 · Cited by 404
Genetic and environmental factors in the cause of Parkinson's disease
Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399
Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373
Gene expression during ER stress–induced apoptosis in neurons
Reimertz, C., Kögel, D., Rami, A., Chittenden, T., & Prehn, J. H. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305149 · Cited by 367
Parkinsonian Mimetics Induce Aspects of Unfolded Protein Response in Death of Dopaminergic Neurons
Holtz, W. A., & O'Malley, K. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211821200 · Cited by 364
Neurotrophin signalling pathways regulating neuronal apoptosis
Miller, F. D., & Kaplan, D. R. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000919 · Cited by 317
Soto‐Otero, R., Méndez‐Álvarez, E., Hermida‐Ameijeiras, Á., Muñoz‐Patiño, A. M., & Labandeira‐Garcia, J. L. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741605.x · Cited by 314
Matteo, V., & Esposito, E. (2003) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007033482959 · Cited by 266
Choi, W.-S., Yoon, S.-Y., Oh, T. H., Choi, E.-J., O'Malley, K. L., & Oh, Y. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990701)57:1<86::aid-jnr9>3.0.co;2-e · Cited by 261
Song, L., De Sarno, P., & Jope, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206047200 · Cited by 256
Presenilins, the Endoplasmic Reticulum, and Neuronal Apoptosis in Alzheimer's Disease
Mattson, M. P., Guo, Q., Furukawa, K., & Pedersen, W. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010001.x · Cited by 247
Lesort, M., Jope, R. S., & Johnson, G. V. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720576.x · Cited by 240
Paschen, W., & Frandsen, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00623.x · Cited by 239
Developmental expression and localization of glycogen synthase kinase-3β in rat brain
Leroy, K., & Brion, J.-P. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00012-5 · Cited by 238
Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho, R., Eggert, A., Hishiki, T., Minturn, J. E., Ikegaki, N., Foster, P., Camoratto, A. M., Evans, A. E., & Brodeur, G. M. (2002) · PubMed · Cited by 228
Andrew, R., Watson, D. G., Best, S. A., Midgley, J. M., Wenlong, H., & Petty, R. K. H. (1993) · Neurochemical Research · doi:10.1007/bf00978370 · Cited by 225
Proapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β
Bijur, G. N., & Jope, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105725200 · Cited by 204
Jaboin, J. J., Kim, C. J., Kaplan, D. R., & Thiele, C. J. (2002) · PubMed · Cited by 201
Self-citationThe GSK3β signaling cascade and neurodegenerative disease
Kaytor, M. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00320-3 · Cited by 195
Crowder, R. J., & Freeman, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006160200 · Cited by 181
Ivaska, J., Nissinen, L., Immonen, N., Eriksson, J. E., Kähäri, V.-M., & Heino, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1352-1359.2002 · Cited by 176
Meier, R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7294 · Cited by 171
Insulin Mimetic Action of Synthetic Phosphorylated Peptide Inhibitors of Glycogen Synthase Kinase-3
Plotkin, B., Kaidanovich‐Beilin, O., Talior‐Volodarsky, I., & Eldar-Finkelman, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047381 · Cited by 151
Hartigan, J. A., & Johnson, G. V. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21395 · Cited by 141
Mass fragmentography of dopamine and 6-hydroxydopamine
Curtius, H. ‐., Wolfensberger, M., Steinmann, B. U., Redweik, U., & Siegfried, J. (1974) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)90882-3 · Cited by 138
Mechanistic Approaches to Parkinson's Disease Pathogenesis
Betarbet, R. S., Sherer, T., Monte, D. A. D., & Greenamyre, J. T. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00468.x · Cited by 137
Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death
Dodel, R. C., Du, Y., Bales, K. R., Ling, Z. D., Carvey, P. M., & Paul, S. M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00318-0 · Cited by 123
Hynes, M., Poulsen, K., Armanini, M. P., Berkemeier, L. R., PHILLIPS, H. S., & Rosenthal, A. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370118 · Cited by 119
Luo, J., West, J. R., & Pantazis, N. J. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb04261.x · Cited by 117
Self-citationCourtney, M. J., Åkerman, K. E. O., & Coffey, E. T. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04201.1997 · Cited by 114
Glazner, G. W., Mu, X., & Springer, J. E. (1998) · The Journal of Comparative Neurology · Cited by 111
Molecular interactions between neurotrophin receptors
Dechant, G. (2001) · Cell and Tissue Research · doi:10.1007/s004410100378 · Cited by 104
Luo, J., & Miller, M. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-10014.1999 · Cited by 99
Self-citationStorch, A., Burkhardt, K., Ludolph, A. C., & Schwarz, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752259.x · Cited by 98
GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease
Bhat, R. V., & Budd, S. L. (2002) · Neurosignals · doi:10.1159/000067423 · Cited by 97
von Coelln, R., Kügler, S., Bähr, M., Weller, M., DICHGANS, J., & Schulz, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00236.x · Cited by 95
Ugarte, S. D., Lin, E., Klann, E., Zigmond, M. J., & Perez, R. G. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10632 · Cited by 92
The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
Youdim, M. B. H., & Riederer, P. (1993) · PubMed · Cited by 91
Daily, D., Vlamis‐Gardikas, A., Offen, D., Mittelman, L. A., Melamed, E., Holmgren, A., & Barzilai, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101400200 · Cited by 88
Thiele, C. J., Cohen, P. S., & Israel, M. A. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1677 · Cited by 88
Self-citationHara, H., Ohta, M., Ohta, K., Kuno, S., & Adachi, T. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.08.021 · Cited by 74
Volpe, B. T., Wildmann, J., & Altar, C. A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00424-7 · Cited by 71
Lin, S., Wei, X., Xu, Y., Yan, C., Dodel, R., Zhang, Y., Liu, J., Klaunig, J. E., Farlow, M., & Du, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02442-6 · Cited by 70
Frei, B. B., & Richter, C. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81192-9 · Cited by 70
Elkon, H., Melamed, E., & Offen, D. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1015160323009 · Cited by 60
Medial nigral dopamine neurons have rich neurotrophin support in humans
Nishio, T., Furukawa, S., Akiguchi, I., & Sunohara, N. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00030 · Cited by 59
Li, Z., Lin, H., Zhu, Y., Wang, M., & Luo, J. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00294-2 · Cited by 59
Self-citationHou, S., Cowan, E., Walker, T., Ohan, N., Dove, M., Rasqinha, I., & MacManus, J. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00402.x · Cited by 57
Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis
Nishio, T., Sunohara, N., & Furukawa, S. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00073 · Cited by 55
Foulstone, E. J., Tavaré, J. M., & Gunn‐Moore, F. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00166-4 · Cited by 54
Benisty, S., Boissière‐Michot, F., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00126-2 · Cited by 46
Luo, J., Sun, Y., Lin, H., Qian, Y. R., Li, Z., Leonard, S. S., Huang, C., & Shi, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208295200 · Cited by 44
Self-citationCalretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion
Tsuboi, K., Kimber, T. A., & Shults, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02219-8 · Cited by 41
Sun, Y., Lin, H., Zhu, Y., Ma, C., Ye, J., & Luo, J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10132 · Cited by 19
Self-citationSignaling Pathways Mediate the Neuroprotective Effects of GDNF
Neff, F., Noelker, C., Eggert, K. M., & Schlegel, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04608.x · Cited by 19
Cited by
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
Beurel, E., & Jope, R. S. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.006 · Cited by 541
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Metadata
- Authors
- Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., & Luo, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05-07
- Volume
- 18
- Issue
- 10
- Pages
- 1162-1164
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2153244109
- Cited by
- 310
- References
- 82
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.